Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA433102
Max Phase: Preclinical
Molecular Formula: C27H37F6N3O8S2
Molecular Weight: 481.68
Molecule Type: Small molecule
Associated Items:
ID: ALA433102
Max Phase: Preclinical
Molecular Formula: C27H37F6N3O8S2
Molecular Weight: 481.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H](CCSC)NC(=O)[C@@H]1C[C@H](Oc2ccccc2)CN1CC/C=C/[C@@H](N)CS.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C23H35N3O4S2.2C2HF3O2/c1-29-23(28)20(11-13-32-2)25-22(27)21-14-19(30-18-9-4-3-5-10-18)15-26(21)12-7-6-8-17(24)16-31;2*3-2(4,5)1(6)7/h3-6,8-10,17,19-21,31H,7,11-16,24H2,1-2H3,(H,25,27);2*(H,6,7)/b8-6+;;/t17-,19+,20+,21+;;/m1../s1
Standard InChI Key: CLGLOYWZURJEJJ-CWMTVFHUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.68 | Molecular Weight (Monoisotopic): 481.2069 | AlogP: 2.12 | #Rotatable Bonds: 13 |
Polar Surface Area: 93.89 | Molecular Species: BASE | HBA: 8 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.23 | CX Basic pKa: 9.24 | CX LogP: 2.00 | CX LogD: 0.00 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.23 | Np Likeness Score: -0.20 |
1. O'Connell CE, Ackermann K, Rowell CA, Garcia AM, Lewis MD, Schwartz CE.. (1999) Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors., 9 (14): [PMID:10450988] [10.1016/s0960-894x(99)00342-x] |
Source(1):